Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.
N Engl J Med. 2022 Apr 11. doi: 10.1056/NEJMoa2202170. Online ahead of print.
N Engl J Med. 2022.
PMID: 35403841